Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hepatitis C Antibodies | 5 | 2019 | 120 | 1.76 | Why? |
| Rodentia | 3 | 2020 | 235 | 1.50 | Why? |
| Hepacivirus | 11 | 2019 | 1509 | 1.40 | Why? |
| Viral Hepatitis Vaccines | 2 | 2019 | 58 | 0.93 | Why? |
| Hepatitis C | 7 | 2019 | 1514 | 0.72 | Why? |
| Viral Envelope Proteins | 7 | 2019 | 3539 | 0.65 | Why? |
| Alphacoronavirus | 1 | 2019 | 392 | 0.54 | Why? |
| Hepatitis C, Chronic | 4 | 2019 | 973 | 0.38 | Why? |
| Lung Transplantation | 1 | 2019 | 1554 | 0.34 | Why? |
| Polymerase Chain Reaction | 4 | 2020 | 6740 | 0.32 | Why? |
| Lectins | 2 | 2019 | 311 | 0.30 | Why? |
| Cloning, Molecular | 2 | 2019 | 1036 | 0.29 | Why? |
| Antibodies, Neutralizing | 7 | 2021 | 25288 | 0.29 | Why? |
| Evolution, Molecular | 1 | 2019 | 3691 | 0.29 | Why? |
| Tracheostomy | 3 | 2021 | 1963 | 0.25 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.22 | Why? |
| Gorilla gorilla | 1 | 2021 | 53 | 0.22 | Why? |
| Adenovirus Vaccines | 1 | 2021 | 103 | 0.20 | Why? |
| Murinae | 1 | 2019 | 25 | 0.20 | Why? |
| Arvicolinae | 1 | 2019 | 49 | 0.19 | Why? |
| Microarray Analysis | 1 | 2020 | 262 | 0.19 | Why? |
| Consensus Sequence | 1 | 2018 | 81 | 0.19 | Why? |
| Polyomavirus | 1 | 2018 | 37 | 0.19 | Why? |
| Hepatocytes | 2 | 2019 | 549 | 0.19 | Why? |
| Mannose-Binding Lectin | 1 | 2019 | 131 | 0.18 | Why? |
| Guinea Pigs | 1 | 2018 | 420 | 0.17 | Why? |
| Virion | 3 | 2020 | 1444 | 0.17 | Why? |
| Polyomavirus Infections | 1 | 2018 | 156 | 0.16 | Why? |
| Shrews | 1 | 2016 | 28 | 0.16 | Why? |
| Genome, Viral | 1 | 2019 | 13157 | 0.16 | Why? |
| Polymers | 1 | 2020 | 507 | 0.15 | Why? |
| Genotype | 5 | 2019 | 4697 | 0.15 | Why? |
| Compassionate Use Trials | 1 | 2020 | 632 | 0.15 | Why? |
| Coronavirus | 3 | 2020 | 18339 | 0.15 | Why? |
| Rabbits | 1 | 2019 | 1171 | 0.14 | Why? |
| Adenoviridae | 1 | 2021 | 1151 | 0.14 | Why? |
| Substance Abuse, Intravenous | 1 | 2019 | 411 | 0.14 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 526 | 0.12 | Why? |
| Sequence Analysis, DNA | 2 | 2019 | 2830 | 0.12 | Why? |
| Vaccines, Subunit | 1 | 2018 | 1088 | 0.12 | Why? |
| Carcinoma, Hepatocellular | 2 | 2019 | 1222 | 0.12 | Why? |
| Recombination, Genetic | 1 | 2019 | 1265 | 0.11 | Why? |
| Antimicrobial Stewardship | 1 | 2020 | 931 | 0.11 | Why? |
| Asia | 1 | 2019 | 2399 | 0.11 | Why? |
| Rats | 1 | 2019 | 2764 | 0.11 | Why? |
| Immunoglobulins | 1 | 2016 | 811 | 0.11 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2019 | 1267 | 0.11 | Why? |
| Neutralization Tests | 3 | 2019 | 6698 | 0.10 | Why? |
| Minority Groups | 1 | 2020 | 1631 | 0.10 | Why? |
| Tissue Donors | 1 | 2019 | 1679 | 0.10 | Why? |
| London | 3 | 2021 | 2166 | 0.10 | Why? |
| Immune Evasion | 1 | 2019 | 2081 | 0.09 | Why? |
| Membrane Proteins | 1 | 2019 | 1733 | 0.09 | Why? |
| Universities | 2 | 2021 | 4374 | 0.09 | Why? |
| Respiratory System | 1 | 2021 | 3213 | 0.09 | Why? |
| Animals | 6 | 2021 | 78931 | 0.09 | Why? |
| Recombinant Proteins | 1 | 2018 | 3786 | 0.09 | Why? |
| Cross Reactions | 1 | 2018 | 4374 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2019 | 1666 | 0.08 | Why? |
| United Kingdom | 3 | 2021 | 18046 | 0.08 | Why? |
| Interferons | 1 | 2019 | 2885 | 0.08 | Why? |
| Cell Line, Tumor | 3 | 2021 | 3608 | 0.08 | Why? |
| Phylogeny | 3 | 2021 | 13341 | 0.08 | Why? |
| HEK293 Cells | 4 | 2021 | 8394 | 0.07 | Why? |
| Vaccines, Synthetic | 1 | 2018 | 3231 | 0.07 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.07 | Why? |
| Virus Internalization | 3 | 2019 | 7921 | 0.07 | Why? |
| Genetic Variation | 1 | 2019 | 3919 | 0.07 | Why? |
| Europe | 2 | 2019 | 12702 | 0.07 | Why? |
| Catheterization, Swan-Ganz | 1 | 2004 | 30 | 0.07 | Why? |
| Antibodies, Monoclonal | 3 | 2019 | 8041 | 0.07 | Why? |
| England | 3 | 2021 | 5116 | 0.07 | Why? |
| Genes, Viral | 2 | 2019 | 1428 | 0.06 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.06 | Why? |
| Genetic Vectors | 2 | 2021 | 1600 | 0.06 | Why? |
| Epitope Mapping | 2 | 2017 | 1240 | 0.06 | Why? |
| Hypercapnia | 1 | 2004 | 172 | 0.06 | Why? |
| Humans | 26 | 2021 | 930598 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.06 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.06 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Immunity, Innate | 1 | 2019 | 6570 | 0.05 | Why? |
| Immunotherapy | 1 | 2014 | 2421 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Critical Care | 1 | 2004 | 14081 | 0.05 | Why? |
| Adsorption | 1 | 2020 | 261 | 0.05 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.05 | Why? |
| Macaca | 1 | 2021 | 388 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.05 | Why? |
| Mutagenesis, Site-Directed | 1 | 2019 | 449 | 0.04 | Why? |
| Mice, SCID | 1 | 2017 | 225 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.04 | Why? |
| HeLa Cells | 1 | 2021 | 1303 | 0.04 | Why? |
| Genes, Reporter | 1 | 2019 | 472 | 0.04 | Why? |
| Serum | 1 | 2019 | 294 | 0.04 | Why? |
| Virus Release | 1 | 2019 | 253 | 0.04 | Why? |
| DNA, Complementary | 1 | 2019 | 568 | 0.04 | Why? |
| Carbon Dioxide | 1 | 2004 | 917 | 0.04 | Why? |
| Cells, Cultured | 2 | 2019 | 5835 | 0.04 | Why? |
| Safety | 1 | 2004 | 1583 | 0.04 | Why? |
| Biomarkers | 1 | 2019 | 23361 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.04 | Why? |
| Cell Line | 2 | 2021 | 12040 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2020 | 865 | 0.03 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Male | 7 | 2021 | 367725 | 0.03 | Why? |
| Respiration, Artificial | 3 | 2021 | 22116 | 0.03 | Why? |
| Complement Activation | 1 | 2019 | 949 | 0.03 | Why? |
| Vascular Surgical Procedures | 1 | 2021 | 882 | 0.03 | Why? |
| Ultraviolet Rays | 1 | 2020 | 1272 | 0.03 | Why? |
| Liver Transplantation | 2 | 2017 | 2864 | 0.03 | Why? |
| Escherichia coli | 1 | 2019 | 1547 | 0.03 | Why? |
| Female | 6 | 2021 | 380317 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2017 | 2219 | 0.03 | Why? |
| Base Sequence | 1 | 2019 | 3581 | 0.03 | Why? |
| Lung | 1 | 2019 | 31049 | 0.03 | Why? |
| Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2016 | 1083 | 0.02 | Why? |
| Mice | 2 | 2021 | 21357 | 0.02 | Why? |
| Mass Screening | 2 | 2021 | 8005 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2019 | 2585 | 0.02 | Why? |
| Immunologic Memory | 1 | 2019 | 3362 | 0.02 | Why? |
| State Medicine | 1 | 2020 | 2847 | 0.02 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.02 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Adult | 5 | 2021 | 244371 | 0.02 | Why? |
| Epitopes | 1 | 2017 | 4113 | 0.02 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Clinical Trials as Topic | 1 | 2004 | 7330 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Research Design | 1 | 2020 | 5830 | 0.02 | Why? |
| Aged | 4 | 2021 | 215776 | 0.02 | Why? |
| Students | 1 | 2021 | 5255 | 0.02 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.01 | Why? |
| Protein Binding | 1 | 2019 | 11430 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2020 | 10649 | 0.01 | Why? |
| Viral Nonstructural Proteins | 1 | 2019 | 4810 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.01 | Why? |
| Viral Proteins | 1 | 2016 | 7370 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
Ball's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(157)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(168)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_